Corante

About this Author
Derek Lowe
Derek Lowe, an Arkansan by birth, got his BA from Hendrix College and his PhD in organic chemistry from Duke before spending time in Germany on a Humboldt Fellowship on his post-doc. He's worked for several major pharmaceutical companies since 1989 on drug discovery projects against schizophrenia, Alzheimer's, diabetes, osteoporosis and other diseases. To contact Derek email him directly: derekb.lowe@gmail.com Twitter: Dereklowe

Chemistry and Drug Data: Drugbank
Emolecules
ChemSpider
Chempedia Lab
Synthetic Pages
Organic Chemistry Portal
PubChem
Not Voodoo
DailyMed
Druglib
Clinicaltrials.gov

Chemistry and Pharma Blogs:
Org Prep Daily
The Haystack
MedChem Buzz
Kilomentor
On Pharma
A New Merck, Reviewed
Liberal Arts Chemistry
One in Ten Thousand
Electron Pusher
Periodic Tabloid
All Things Metathesis
C&E News Blog
Propter Doc
Chemiotics II
The Chemical Notebook
Chemical Space
Noel O'Blog
In Vivo Blog
Terra Sigilatta
Chirality
BBSRC/Douglas Kell
ChemBark
Drug Discovery Opinion
Realizations in Biostatistics
Chemjobber
Pharmalot
WSJ Health Blog
ChemSpider Blog
Pharmagossip
Med-Chemist
Organic Chem - Education & Industry
Useful Chemistry
Chiral Jones
Pharma Strategy Blog
No Name No Slogan
Practical Fragments
SimBioSys
The Curious Wavefunction
Natural Product Man
Totally Synthetic
Fragment Literature
The F- Blog
Chemistry World Blog
Synthetic Nature
Chemistry Blog
Synthesizing Ideas
Carbon-Based Curiosities
Experimental Error
Business|Bytes|Genes|Molecules
Eye on FDA
Sigma-Aldrich ChemBlogs
Chemical Forums
Depth-First
Symyx Blog
P212121
ChemCafe
Sceptical Chymist
Lamentations on Chemistry
Computational Organic Chemistry
Mining Drugs
Henry Rzepa


Science Blogs and News:
Bad Science
The Loom
Uncertain Principles
Fierce Biotech
Blogs for Industry
Omics! Omics!
Young Female Scientist
Notional Slurry
Nobel Intent
SciTech Daily
Science Blog
FuturePundit
Aetiology
Gene Expression (I)
Gene Expression (II)
Sciencebase
Pharyngula
Adventures in Ethics and Science
Transterrestrial Musings
Slashdot Science
A Scientist's Life
Speculist
Cosmic Variance
The Capsule
Zeroth Order Approximation
Biology News Net


Medical Blogs
Med Tech Sentinel
DB's Medical Rants
Science-Based Medicine
GruntDoc
The Health Care Blog
Respectful Insolence
Black Triangle
Diabetes Mine


Economics and Business
Marginal Revolution
Arnold Kling
The Volokh Conspiracy
Knowledge Problem
The Stalwart


Politics / Current Events
Virginia Postrel
Tinkerty Tonk
Instapundit
Megan McArdle
Mickey Kaus
Colby Cosh
Alien Corn
No Watermelons


Belles Lettres
Two Blowhards
Critical Mass
Arts and Letters Daily
God of the Machine
Armavirumque
About Last Night
In the Pipeline: Don't miss Derek Lowe's excellent commentary on drug discovery and the pharma industry in general at In the Pipeline

In the Pipeline

« Ardea's Gout Drug Progresses | Main | Good News Versus Sleeping Sickness »

April 1, 2010

What Do Nanoparticles Really Look Like?

Email This Entry

Posted by Derek

We're all going to be hearing a lot about nanoparticles in the next few years (some may feel as if they've already heard quite enough, but there's nothing to be done about that). The recent report of preliminary siRNA results using them as a delivery system will keep things moving along with even more interest. So it's worth checking out this new paper, which illustrates how we're going to have to think about these things.

The authors show that it's not necessarily the carefully applied coat proteins of these nanoparticles that are the first thing a cell notices. Rather, it's the second sphere of endogenous proteins that end up associated with the particle, which apparently can be rather specific and persistent. The authors make their case with admirable understatement:

The idea that the cell sees the material surface itself must now be re-examined. In some specific cases the cell receptor may have a higher preference for the bare particle surface, but the time scale for corona unbinding illustrated here would still typically be expected to exceed that over which other processes (such as nonspecific uptake) have occurred. Thus, for most cases it is more likely that the biologically relevant unit is not the particle, but a nano-object of specified size, shape, and protein corona structure. The biological consequences of this may not be simple.

Update: fixed this post by finally adding the link to the paper!

Comments (3) + TrackBacks (0) | Category: Biological News | Pharmacokinetics


COMMENTS

1. Ben Thuronyi on April 1, 2010 9:41 AM writes...

Looks like an interesting paper -- how about a link or citation? :)

Permalink to Comment

2. Tuck on April 1, 2010 10:27 AM writes...

Is this the article?

>>What the Cell “Sees” in Bionanoscience

http://pubs.acs.org/doi/abs/10.1021/ja910675v

Permalink to Comment

3. Alf on April 2, 2010 1:56 AM writes...

Very cool, who knows what type of target modulation is possible with these critters.

Permalink to Comment

POST A COMMENT




Remember Me?



EMAIL THIS ENTRY TO A FRIEND

Email this entry to:

Your email address:

Message (optional):




RELATED ENTRIES
One More on That Buckyball Longevity Paper
More Reaction Discovery (Now With Antibody Detection)
PhDs On Food Stamps?
Laboratory Crime, Not Paying
Buckyball Longevity: The Lead Author Replies
More Details
You're A Peer, Too, You Know
The CETP Saga Continues (And It's Not Getting More Entertaining)